← Leaderboards
Mark W Jackson
Cleveland Clinic Foundation
$14,843,139
Attributed
$16,011,935
Total exposure
17
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,011,935 · 17
By mechanism
R01$5,272,045 · 2
R25$3,610,234 · 2
T32$2,728,636 · 1
P01$1,575,852 · 2
R21$1,506,506 · 4
P30$1,010,766 · 4
Top collaborators
- Goutham Narla6 shared
- George Robert Stark2 shared
- David Wald2 shared
Most similar at Cleveland Clinic Foundation
Same institution · by research overlap
- George Robert Stark$19,236,463
- Meredith Bond$7,705,624
- Christine S Moravec$1,787,117
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMemberTumorProgramsTrainingMediatingCancer CellSignal TransductionResearch PersonnelFamilyInnovationCancer BiologyGrantCellsResistancePhosphorylationComprehensive Cancer CenterUndergraduate StudentLaboratoriesCareerMentorsFacultyCancer EducationRecurrence
Grant awards (64)
Cancer-focused Summer Undergraduate Research (CanSUR) Program$431,508
R25 · FY2025 · CA · contact PI
Case CCC Youth Engaged in Science, 09/01/2022-08/31/2027$416,067
R25 · FY2025 · CA · contact PI
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure$412,810
R01 · FY2025 · CA · contact PI
Shifting the balance between IFN-I and TGF-beta to improve cancer therapy$400,890
P01 · FY2025 · CA · contact PI
Cancer Biology Training Grant$276,972
T32 · FY2025 · CA · contact PI
Cancer Research Training and Education Coordination$165,772
P30 · FY2025 · CA · contact PI
Cancer-focused Summer Undergraduate Research (CanSUR) Program$433,027
R25 · FY2024 · CA · contact PI
Case CCC Youth Engaged in Science, 09/01/2022-08/31/2027$430,042
R25 · FY2024 · CA · contact PI
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure$392,171
R01 · FY2024 · CA · contact PI
Shifting the balance between IFN-I and TGF-beta to improve cancer therapy$380,847
P01 · FY2024 · CA · contact PI
Cancer Biology Training Grant$285,554
T32 · FY2024 · CA · contact PI
Cancer Research Career Enhancement and Related Activities$98,479
P30 · FY2024 · CA · contact PI
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure$404,553
R01 · FY2023 · CA · contact PI
Shifting the balance between IFN-I and TGF-beta to improve cancer therapy$393,225
P01 · FY2023 · CA · contact PI
Case CCC Youth Engaged in Science, 09/01/2022-08/31/2027$315,251
R25 · FY2023 · CA · contact PI
Cancer Biology Training Grant$267,126
T32 · FY2023 · CA · contact PI
Cancer-focused Summer Undergraduate Research (CanSUR) Program$211,324
R25 · FY2023 · CA · contact PI
Cancer Research Career Enhancement and Related Activities$98,479
P30 · FY2023 · CA · contact PI
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure$404,553
R01 · FY2022 · CA · contact PI
Shifting the balance between IFN-I and TGF-beta to improve cancer therapy$400,890
P01 · FY2022 · CA · contact PI
Cancer-focused Summer Undergraduate Research (CanSUR) Program$303,668
R25 · FY2022 · CA · contact PI
Cancer Biology Training Grant$211,073
T32 · FY2022 · CA · contact PI
Cancer Research Career Enhancement and Related Activities$130,205
P30 · FY2022 · CA · contact PI
Defining the role of FAM83B in lung cancer using a new mouse model$80,500
R03 · FY2022 · CA · contact PI
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure$412,810
R01 · FY2021 · CA · contact PI
Cancer-focused Summer Undergraduate Research (CanSUR) Program$321,831
R25 · FY2021 · CA · contact PI
Cancer Biology Training Grant$225,116
T32 · FY2021 · CA · contact PI
Cancer Research Career Enhancement and Related Activities$129,182
P30 · FY2021 · CA · contact PI
Defining the role of FAM83B in lung cancer using a new mouse model$80,500
R03 · FY2021 · CA · contact PI
FAM83B-mediated activation of EGFR signaling$338,794
R01 · FY2020 · CA · contact PI
Cancer Biology Training Grant$158,768
T32 · FY2020 · CA · contact PI
Cancer Research Career Enhancement and Related Activities$127,950
P30 · FY2020 · CA · contact PI
Cancer-focused Summer Undergraduate Research (CanSUR) Program$100,514
R25 · FY2020 · CA · contact PI
FAM83B-mediated activation of EGFR signaling$328,629
R01 · FY2019 · CA · contact PI
Cancer-focused Summer Undergraduate Research (CanSUR) Program$323,501
R25 · FY2019 · CA · contact PI
Cancer Biology Training Grant$204,535
T32 · FY2019 · CA · contact PI
Cancer Research Career Enhancement and Related Activities$124,089
P30 · FY2019 · CA · contact PI
FAM83B-mediated activation of EGFR signaling$338,794
R01 · FY2018 · CA · contact PI
Cancer-focused Summer Undergraduate Research (CanSUR) Program$323,501
R25 · FY2018 · CA · contact PI
Cancer Biology Training Grant$246,088
T32 · FY2018 · CA · contact PI
Cancer Research Career Enhancement and Related Activities$127,351
P30 · FY2018 · CA · contact PI
Cancer Research Career Enhancement and Related Activities$9,259
P30 · FY2018 · CA · contact PI
FAM83B-mediated activation of EGFR signaling$338,794
R01 · FY2017 · CA · contact PI
Cancer Biology Training Grant$225,136
T32 · FY2017 · CA · contact PI
Interferon-beta inhibits the expansion of cancer stem-cells$206,843
R21 · FY2017 · CA · contact PI
Defining the role of FAM83A in Herceptin-resistant breast cancer$206,843
R21 · FY2017 · CA · contact PI
FAM83B-mediated activation of EGFR signaling$338,794
R01 · FY2016 · CA · contact PI
Cancer Biology Training Grant$191,865
T32 · FY2016 · CA · contact PI
Defining the role of FAM83A in Herceptin-resistant breast cancer$172,369
R21 · FY2016 · CA · contact PI
Interferon-beta inhibits the expansion of cancer stem-cells$172,369
R21 · FY2016 · CA · contact PI
Cancer Biology Training Grant$224,404
T32 · FY2015 · CA · contact PI
Identification of a noval oncogene using validation-based insertional mutagenesis$306,522
R01 · FY2014 · CA · contact PI
Cancer Biology Training Grant$211,999
T32 · FY2014 · CA · contact PI
A RAS-FAM83A Regulatory Loop as a Novel Therapeutic Target for Pancreatic Cancer$167,198
R21 · FY2014 · CA · contact PI
A Strategy for Reactivating p53 in Cancer Stem Cells Using a Novel HdmX Inhibitor$167,198
R21 · FY2014 · CA · contact PI
Identification of a noval oncogene using validation-based insertional mutagenesis$297,042
R01 · FY2013 · CA · contact PI
A Strategy for Reactivating p53 in Cancer Stem Cells Using a Novel HdmX Inhibitor$206,843
R21 · FY2013 · CA · contact PI
A RAS-FAM83A Regulatory Loop as a Novel Therapeutic Target for Pancreatic Cancer$206,843
R21 · FY2013 · CA · contact PI
Identification of a noval oncogene using validation-based insertional mutagenesis$316,002
R01 · FY2012 · CA · contact PI
Identification of a noval oncogene using validation-based insertional mutagenesis$316,002
R01 · FY2011 · CA · contact PI
Identification of a noval oncogene using validation-based insertional mutagenesis$325,775
R01 · FY2010 · CA · contact PI
p53-dependent regulation of VEGF expression and activity$51,548
F32 · FY2005 · HL
p53-dependent regulation of VEGF expression and activity$48,928
F32 · FY2004 · HL
p53-dependent regulation of VEGF expression and activity$46,420
F32 · FY2003 · HL